SHSteven R. Horbal

Steven R. Horbal

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Steven R. Horbal has a total of 83 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Composite Pulmonary Embolism Shock Score and Outcomes in Intermediate-Risk Acute Pulmonary Embolism: A Multicenter PERT Consortium Registry Study

    by Joseph M. Kim, Steven R. Horbal, Lorenzo V. Arvanitis, Christian Mewaldt, Sripal Bangalore, Robert W. Yeh, Eric A. Secemsky, Brett J. Carroll

  • Trends in catheter-directed therapy and in-hospital outcomes among patients with acute pulmonary embolism: insights from a multicentre national quality assurance database registry

    by Ioannis T Farmakis, Steven Horbal, John M Moriarty, Mahir Elder, Thomas Todoran, Rachel P Rosovsky, Eric Lehr, Matthew D Langston, Seth I Sokol, Kenneth Rosenfield, et al.

    Aims: Multidisciplinary pulmonary embolism response teams (PERTs) are being established in hospitals worldwide to address the increasing complexity in acute PE management. To identify recent trends in PERT decisions regarding advanced treatment of acute severe PE. Methods and results: We analysed data from the prospective multicentre PERT™ Consortium registry (years 2018–2024), focusing on catheter-directed treatment (CDT) and including systemic thrombolysis, surgical embolectomy, and extracorporeal membrane oxygenation (ECMO). An age-, sex-, and PE risk-matched population from the US Nationwide Inpatient Sample (NIS) was used for comparison. Among 11 436 patients enrolled at 51 sites (median age, 65 years; 13.7% high-risk and 62.5% intermediate-risk PE), 2639 (23.1%) underwent CDT. Of those, 140 (5.3%) underwent catheter-directed thrombolysis without ultrasound, 851 (32.2%) ultrasound-assisted catheter thrombolysis, and 1534 (58.1%) mechanical thrombectomy/aspiration. Systemic thrombolysis was used in 5.6%, surgical embolectomy in 1.1%, and ECMO in 1.6% of all patients. Trends of CDT increased over time (+0.36% quarterly by linear regression; P = 0.002), with increase in mechanical thrombectomy (+0.83%; P < 0.001) and decrease in catheter-directed thrombolysis (−0.4%; P = 0.001). Matching 10 883 patients from the PERT™ Consortium registry to the NIS population, we found a 22% (95% CI, 21–23%) standardized mean difference in CDT use, 1.3% (0.6–2.0%) lower in-hospital mortality, and 0.75 (0.2–1.3) fewer days of hospital stay among PERT™ Consortium registry patients. Conclusion: In a national quality assurance database of patients with PE included in the PERT registry, the use of catheter-directed treatment increased over time. Compared with a nationwide NIS sample, these patients had lower in-hospital mortality and shorter hospital length of stay.


  • Open Access

    Utilizing Opportunistic Computed Tomography Imaging to Refine Lean Body Weight Estimates in Patients with Obesity

    by Radin Alikhani, Steven Horbal, Amy E. Rothberg, Manjunath P. Pai

    Introduction While dual-energy X-ray absorptiometry (DEXA) is the gold standard for measuring lean body weight (LBW), computed tomography (CT) provides muscle composition and distribution metrics that can refine LBW for better weight-based dosing. We explored how existing computed tomography (CT) images could be utilized to better estimate LBW. Methods Sixty-three adult patients (71.4% female) with a median age of 53.4 years and mean BMI of 36.84 having both DEXA and CT scans were retrospectively analyzed to assess the relationship between CT-based skeletal muscle variables and DEXA-derived LBW. Results Linear regression results revealed significant correlations. CT-derived skeletal muscle area (SMA) strongly predicted DEXA-derived LBW (p value < 0.05 and R2 between 0.67 and 0.80) at four different vertebra levels. DEXA-derived LBW showed a strong correlation with a height, weight, and sex-based estimate of LBW using an equation developed in 2005 (LBW2005). A final model incorporating SMA with the LBW2005 equation improved the coefficient of determination at all four vertebra levels (R2 0.82–0.86). Discussions/Conclusion This study demonstrates opportunistic CT scan data may improve an existing equation for LBW that has been predictive of select drug pharmacokinetic parameters. Improving LBW estimation may enable improved personalized drug dosing strategies in patients with obesity and other populations that benefit from using LBW over total body weight.


  • Open Access

    A comparison between radiomic biological age and chronological age in estimating kidney function

    by Radin Alikhani, Steven R. Horbal, Manjunath P. Pai

    Accurate kidney function estimation hinges on essential markers of age and body size. The relative benefit of both markers has been debated with the emerging biological age and novel body size descriptors. We used radiomic biomarkers of age-related changes in body composition to construct new biological age indices as covariates of kidney function. A retrospective cohort of hospitalized patients with plasma concentrations of aminoglycosides and computed tomography images were evaluated. Aminoglycoside clearance served as a kidney function surrogate. A population pharmacokinetic model was constructed to determine whether biological age indices improved aminoglycoside clearance estimation compared to chronological age. The final dataset included 156 patients (51.92% female) with a median (minimum-maximum) age and body weight of 58 [21, 93] years and 81 [43.8, 139.3] Kg. A 1-compartment clearance model with linear elimination, incorporating biological index, serum creatinine, and drug type best fits the concentration-time data. The best radiomic biological age model included dorsal muscle group area, bone mineral density, visceral fat area, and subcutaneous fat density. The radiomic biological age model offered a modest improvement over the chronological age model. This work offers a proof-of-concept, highlighting the potential for more precise methods for aging-related kidney function estimation to aid personalized pharmacotherapy.


  • Open Access

    Radiomic‐based biomarkers: Transforming age and body composition metrics into personalized age‐informed indices

    by Radin Alikhani, Steven R. Horbal, Amy E. Rothberg, Manjunath P. Pai

    Chronological age has been the standard for quantifying the aging process. While it is simple to quantify it cannot fully discern the biological variability of aging between individuals. The growing body of interest in this variability of human aging has led to the introduction of new biomarkers to operationalize biological age. The inclusion of body composition may provide additional value to biological aging as a prediction and estimation factor of individual health outcomes. Diagnostic images based on radiomic techniques such as Computed Tomography contain an untapped wealth of patient‐specific data that remain inaccessible to healthcare providers. These images are beneficial for collecting information from body composition that adds precision and granularity when compared to traditional measures. This information can subsequently be aggregated to construct models for changes in the human body associated with aging. In addition, aging leads to a natural decline in the best parameter of drug dosing in older adults, glomerular filtration rate. Since the conventional models of kidney function are correlated with age and body composition, the radiomic biomarkers representing age‐related changes in body composition may also serve as potential new imaging biomarkers of kidney function for personalized dosing. Our review introduces potential radiomic biomarkers as measures of body composition change targeting the aging processes. As a functional example, we have hypothesized an age‐related model of radiomics as a covariate of kidney function to improve personalized dosing. Future research focusing on evaluating this hypothesis in human subject studies is acknowledged.


  • Statistical Methods for Cardiovascular Outcomes Studies

    by Aurelian Bidulescu, Steven R. Horbal, Andrew D. Althouse


  • Open Access

    Independent Associations of Aortic Calcification with Cirrhosis and Liver Related Mortality in Veterans with Chronic Liver Disease

    by Steven R. Horbal, Patrick X. Belancourt, Peng Zhang, Sven A. Holcombe, Sameer Saini, Stewart C. Wang, Anne E. Sales, Grace L. Su

    Introduction Abdominal aortic calcifications (AAC) are incidentally found on medical imaging and useful cardiovascular burden approximations. The Morphomic Aortic Calcification Score (MAC) leverages automated deep learning methods to quantify and score AACs. While associations of AAC and non-alcoholic fatty liver disease (NAFLD) have been described, relationships of AAC with other liver diseases and clinical outcome are sparse. This study’s purpose was to evaluate AAC and liver-related death in a cohort of Veterans with chronic liver disease (CLD). Methods We utilized the VISN 10 CLD cohort, a regional cohort of Veterans with the three forms of CLD: NAFLD, hepatitis C (HCV), alcohol-associated (ETOH), seen between 2008 and 2014, with abdominal CT scans (n = 3604). Associations between MAC and cirrhosis development, liver decompensation, liver-related death, and overall death were evaluated with Cox proportional hazard models. Results The full cohort demonstrated strong associations of MAC and cirrhosis after adjustment: HR 2.13 (95% CI 1.63, 2.78), decompensation HR 2.19 (95% CI 1.60, 3.02), liver-related death HR 2.13 (95% CI 1.46, 3.11), and overall death HR 1.47 (95% CI 1.27, 1.71). These associations seemed to be driven by the non-NAFLD groups for decompensation and liver-related death [HR 2.80 (95% CI 1.52, 5.17; HR 2.34 (95% CI 1.14, 4.83), respectively]. Discussion MAC was strongly and independently associated with cirrhosis, liver decompensation, liver-related death, and overall death. Surprisingly, stratification results demonstrated comparable or stronger associations among those with non-NAFLD etiology. These findings suggest abdominal aortic calcification may predict liver disease severity and clinical outcomes in patients with CLD.


  • Open Access

    Reference distributions of aortic calcification and association with Framingham risk score

    by Steven R. Horbal, Brian A. Derstine, Edward Brown, Grace L. Su, Stewart C. Wang, Sven A. Holcombe

    Evidence supporting aortic calcification as a leverageable cardiovascular risk factor is rapidly growing. Given aortic calcification’s potential as a clinical correlate, we assessed granular vertebral-indexed calcification measurements of the abdominal aorta in a well curated reference population. We evaluated the relationship of aortic calcification measurements with Framingham risk scores. After exclusion, 4073 participants from the Reference Analytic Morphomic Population with varying vertebral levels were included. The percent of the aortic wall calcified was used to assess calcification burden at the L1–L4 levels. Descriptive statistics of participants, sex-specific vertebral indexed calcification measurements, relational plots, and relevant associations are reported. Mean aortic attenuation was higher in female than male participants. Overall, mean aortic calcium was higher with reference to inferior abdominal aortic measurements and demonstrated significant differences across all abdominal levels [L3 Area (mm\(^2\)): Females 6.34 (sd 16.60), Males 6.23 (sd 17.21); L3 Volume (mm\(^3\)): Females 178.90 (sd 474.19), Males 195.80 (sd 547.36); Wall Calcification (%): Females (L4) 6.97 (sd 16.03), Males (L3) 5.46 (13.80)]. Participants with elevated calcification had significantly higher Framingham risk scores compared to participants with normal calcification scores. Opportunistically measuring aortic calcification may inform further cardiovascular risk assessment and enhance cardiovascular event surveillance efforts.